Literature DB >> 15956091

Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?

A V Ramanan1, A A Grom.   

Abstract

'Science is the systematic classification of experience' George Henry Lewes (1817-78), English philosopher, critic, dramatist, scientist. Juvenile idiopathic arthritis (JIA) is prevalent in about 1 in 1000 children. The earliest formal description of this disease was by Sir George Frederick Still in 1897. This work was done when he was a registrar at the Hospital for Sick Children, Great Ormond Street, London. In this initial description of 19 patients he identified three patterns of arthritis, one of which came to be known later as Still's disease [now known as systemic-onset juvenile idiopathic arthritis (SoJIA)]. Over the next few decades it came to be appreciated that one form of arthritis in children is very different and dominated by the presence of systemic manifestations. Over the last two decades several paediatric rheumatologists have come together to classify juvenile arthritis for purposes of better disease identification and research. All along, the systemic form of juvenile arthritis was always recognized as belonging to a distinct group; in fact for several decades (and even now in some countries) the systemic form of juvenile arthritis was referred to as Still's disease. In this article we will attempt to highlight the reasons why we feel that SoJIA is perhaps not best retained in the company of JIA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956091     DOI: 10.1093/rheumatology/keh710

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

1.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

2.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

3.  Juvenile idiopathic arthritis: management and therapeutic options.

Authors:  Natasha M Ruth; Murray H Passo
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

Review 4.  Update on the pathogenesis and treatment of systemic idiopathic arthritis.

Authors:  Keith A Sikora; Alexei A Grom
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

5.  Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.

Authors:  Shumpei Yokota; Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-12       Impact factor: 5.346

6.  Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis.

Authors:  Claas H Hinze; Ndate Fall; Sherry Thornton; Jun Q Mo; Bruce J Aronow; Gerlinde Layh-Schmitt; Thomas A Griffin; Susan D Thompson; Robert A Colbert; David N Glass; Michael G Barnes; Alexei A Grom
Journal:  Arthritis Res Ther       Date:  2010-06-24       Impact factor: 5.156

7.  Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Authors:  Mark Gorelik; Ndate Fall; Mekibib Altaye; Michael G Barnes; Susan D Thompson; Alexei A Grom; Raphael Hirsch
Journal:  J Rheumatol       Date:  2013-05-15       Impact factor: 4.666

Review 8.  Systemic JIA: new developments in the understanding of the pathophysiology and therapy.

Authors:  Sebastiaan J Vastert; Wietse Kuis; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

9.  Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis.

Authors:  Francisco Hélder C Félix; Luzia Kalyne A M Leal; Juvenia Bezerra Fontenele
Journal:  Rheumatol Int       Date:  2008-12-30       Impact factor: 2.631

10.  Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis.

Authors:  Rachelle Donn; Stuart Ellison; Rebecca Lamb; Thomas Day; Eileen Baildam; Athimalaipet V Ramanan
Journal:  Arthritis Rheum       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.